Share '[Upcoming Webinar] Results from Phase I/II HOPE Clinical Trial of CAP-1002'
Friday, April 28 at 11:00 AM EST
Please join Parent Project Muscular Dystrophy, Coalition Duchenne, and Capricor as we host a webinar Friday, April 28 at 11:00 AM EST to hear a community update on the six-month results from Capricor's randomized Phase I/II HOPE Clinical Trial of CAP-1002 (allogeneic cardiosphere-derived cells), an investigational candidate for the treatment of Duchenne.
You can share this event in two ways…
Share this link:
Send it with your computer's email program: Email this